Five-Year Outcomes after Initial Aflibercept, Bevacizumab, or Ranibizumab Treatment for Diabetic Macular Edema (Protocol T Extension Study)

PURPOSE: Assess follow-up treatment and clinical outcomes at 5 years in eyes initially treated with anti-VEGF therapy for center involved diabetic macular edema (CI-DME) in a 2-year randomized clinical trial. DESIGN: Multicenter cohort study. PARTICIPANTS: Participants with DME and visual acuity (VA...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Ophthalmology
Hlavní autoři: Glassman, Adam R., Wells, John A., Josic, Kristin, Maguire, Maureen G., Antoszyk, Andrew N., Baker, Carl, Beaulieu, Wesley T., Elman, Michael J., Jampol, Lee M., Sun, Jennifer K.
Médium: Artigo
Jazyk:Inglês
Vydáno: 2020
Témata:
Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7483366/
https://ncbi.nlm.nih.gov/pubmed/32402554
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ophtha.2020.03.021
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky